Shaanxi Kanghui Pharmaceutical Co., Ltd. (603139.SS)

CNY 18.4

(-0.97%)

Total Liabilities Summary of Shaanxi Kanghui Pharmaceutical Co., Ltd.

  • Shaanxi Kanghui Pharmaceutical Co., Ltd.'s latest annual total liabilities in 2023 was 1.03 Billion CNY , up 29.66% from previous year.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd.'s latest quarterly total liabilities in 2024 Q3 was 1.03 Billion CNY , up 3.15% from previous quarter.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported annual total liabilities of 795.75 Million CNY in 2022, up 6.78% from previous year.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported annual total liabilities of 745.2 Million CNY in 2021, up 212.75% from previous year.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported quarterly total liabilities of 955.6 Million CNY for 2024 Q1, down -7.38% from previous quarter.
  • Shaanxi Kanghui Pharmaceutical Co., Ltd. reported quarterly total liabilities of 1 Billion CNY for 2024 Q2, up 4.78% from previous quarter.

Annual Total Liabilities Chart of Shaanxi Kanghui Pharmaceutical Co., Ltd. (2023 - 2012)

Historical Annual Total Liabilities of Shaanxi Kanghui Pharmaceutical Co., Ltd. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 1.03 Billion CNY 29.66%
2022 795.75 Million CNY 6.78%
2021 745.2 Million CNY 212.75%
2020 238.27 Million CNY 109.28%
2019 113.85 Million CNY -13.01%
2018 130.87 Million CNY 9.34%
2017 119.69 Million CNY -9.43%
2016 132.15 Million CNY 9.38%
2015 120.82 Million CNY 7.61%
2014 112.27 Million CNY -4.34%
2013 117.36 Million CNY 11.44%
2012 105.31 Million CNY 0.0%

Peer Total Liabilities Comparison of Shaanxi Kanghui Pharmaceutical Co., Ltd.

Name Total Liabilities Total Liabilities Difference
Dali Pharmaceuticalco.,Ltd 92.7 Million CNY -1012.951%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.65 Billion CNY 37.471%
Tasly Pharmaceutical Group Co., Ltd 3.86 Billion CNY 73.306%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.6 Billion CNY 35.861%
Kangmei Pharmaceutical Co., Ltd. 7.19 Billion CNY 85.669%
China Animal Husbandry Industry Co., Ltd. 2.38 Billion CNY 56.709%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.38 Billion CNY 69.556%
Yabao Pharmaceutical Group Co., Ltd 860.33 Million CNY -19.931%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 2.24 Billion CNY 54.023%
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.7 Billion CNY 78.059%
Shandong Lukang Pharmaceutical Co.,Ltd. 4.95 Billion CNY 79.156%
North China Pharmaceutical Company Ltd. 14.68 Billion CNY 92.974%
Zhejiang Shengda Bio-Pharm Co., Ltd. 449.19 Million CNY -129.7%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.66 Billion CNY 71.872%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 4.42 Billion CNY 76.684%
Shandong Buchang Pharmaceuticals Co., Ltd. 9.2 Billion CNY 88.79%
ChengDu ShengNuo Biotec Co.,Ltd. 431.06 Million CNY -139.359%
Changchun BCHT Biotechnology Co. 1.01 Billion CNY -1.553%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 805.75 Million CNY -28.054%
Guobang Pharma Ltd. 2.92 Billion CNY 64.718%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.6 Billion CNY 35.674%
Zhejiang Huahai Pharmaceutical Co., Ltd. 10.34 Billion CNY 90.03%
Harbin Pharmaceutical Group Co., Ltd. 8.37 Billion CNY 87.673%
Zhejiang Medicine Co., Ltd. 2.79 Billion CNY 63.059%
HPGC Renmintongtai Pharmaceutical Corporation 4.55 Billion CNY 77.344%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.49 Billion CNY 70.454%
Lionco Pharmaceutical Group Co.,Ltd. 693.51 Million CNY -48.778%
Humanwell Healthcare (Group) Co.,Ltd. 15.38 Billion CNY 93.295%
Ginwa Enterprise (Group) Inc. 470.12 Million CNY -119.474%
KPC Pharmaceuticals, Inc. 3.9 Billion CNY 73.579%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 440.92 Million CNY -134.01%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 299.24 Million CNY -244.797%
Ningbo Menovo Pharmaceutical Co., Ltd. 2.23 Billion CNY 53.893%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.2 Billion CNY 53.308%
Nanjing Well Pharmaceutical Group Co.,Ltd. 686.22 Million CNY -50.36%
Henan Lingrui Pharmaceutical Co., Ltd. 1.97 Billion CNY 47.71%
Joincare Pharmaceutical Group Industry Co.,Ltd. 13.34 Billion CNY 92.27%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 3.52 Billion CNY 70.738%
Chongqing Taiji Industry(Group) Co.,Ltd 10.52 Billion CNY 90.197%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 40.9 Billion CNY 97.478%
China National Medicines Corporation Ltd. 14.87 Billion CNY 93.063%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.54 Billion CNY 33.003%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.47 Billion CNY 29.937%
Zhongzhu Healthcare Holding Co.,Ltd 422.34 Million CNY -144.305%
Beijing Tongrentang Co., Ltd 9.67 Billion CNY 89.335%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 515.97 Million CNY -99.973%
Jianmin Pharmaceutical Group Co.,Ltd. 1.89 Billion CNY 45.49%
Tibet Weixinkang Medicine Co., Ltd. 436.54 Million CNY -136.355%
CanSino Biologics Inc. 3.86 Billion CNY 73.307%
Zhejiang Hisun Pharmaceutical Co., Ltd. 9.26 Billion CNY 88.862%
Shanghai Jiaoda Onlly Co.,Ltd 475.91 Million CNY -116.804%
Jiang Zhong Pharmaceutical Co.,Ltd 1.6 Billion CNY 35.693%
Mayinglong Pharmaceutical Group Co., LTD. 959.61 Million CNY -7.522%
Cisen Pharmaceutical Co., Ltd. 1.57 Billion CNY 34.338%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 696.15 Million CNY -48.215%
Hunan Warrant Pharmaceutical Co.,Ltd 358.76 Million CNY -187.598%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 56.77 Billion CNY 98.183%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.49 Billion CNY 30.856%
Henan Taloph Pharmaceutical Stock Co.,Ltd 1.95 Billion CNY 47.093%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.64 Billion CNY 71.725%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.89 Billion CNY 78.905%
Shanghai Yizhong Pharmaceutical Co., Ltd. 107.05 Million CNY -863.823%
Tibet Rhodiola Pharmaceutical Holding Co. 1.18 Billion CNY 13.139%
Sichuan Huiyu Pharmaceutical Co., Ltd. 886.91 Million CNY -16.336%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.33 Billion CNY 22.907%